Literature DB >> 25705267

New cardiovascular risk factors and their use for an accurate cardiovascular risk assessment in hypertensive patients.

Oana-Florentina Tautu1, Roxana Darabont2, Sebastian Onciul1, Alexandru Deaconu1, Ioana Comanescu1, Radu Dan Andrei1, Bogdan Dragoescu1, Mircea Cinteza2, Maria Dorobantu1.   

Abstract

OBJECTIVES: To analyze the predictive value of new cardiovascular (CV) risk factors for CV risk assessment in the adult Romanian hypertensive (HT) population.
METHODS: Hypertensive adults aged between 40-65 years of age, identified in national representative SEPHAR II survey were evaluated by anthropometric, BP and arterial stiffness measurements: aortic pulse wave velocity (PWVao), aortic augmentation index (AIXao), revers time (RT) and central systolic blood pressure (SBPao), 12 lead ECGs and laboratory workup. Values above the 4th quartile of mean SBP' standard deviation (s.d.) defined increased BP variability. Log(TG/HDL-cholesterol) defined atherogenic index of plasma (AIP). Serum uric acid levels above 5.70 mg/dl for women and 7.0 mg/dl for males defined hyperuricemia (HUA). CV risk was assessed based on SCORE chart for high CV risk countries. Binary logistic regression using a stepwise likelihood ratio method (adjustments for major confounders and colliniarity analysis) was used in order to validate predictors of high and very high CV risk class.
RESULTS: The mean SBP value of the study group was 148.46±19.61 mmHg. Over forty percent of hypertensives had a high and very high CV risk. Predictors of high/very high CV risk category validated by regression analysis were: increased visit-to-visit BP variability (OR: 2.49; 95%CI: 1.67-3.73), PWVao (OR: 1.12; 95%CI: 1.02-1.22), RT (OR: 0.95; 95% CI: 0.93-0.98), SBPao (OR: 1.01; 95%CI: 1.01-1.03) and AIP (OR: 7.08; 95%CI: 3.91-12.82).
CONCLUSION: The results of our study suggests that the new CV risk factors such as increased BP variability, arterial stiffness indices and AIP are useful tools for a more accurate identification of hypertensives patients at high and very high CV risk.

Entities:  

Year:  2014        PMID: 25705267      PMCID: PMC4296754     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  37 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Evaluating aortic stiffness through an arm cuff oscillometric device: is validation against invasive measurements enough?

Authors:  Gianfranco Parati; Marc De Buyzere
Journal:  J Hypertens       Date:  2010-10       Impact factor: 4.844

3.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

4.  Aortic stiffness is an independent predictor of fatal stroke in essential hypertension.

Authors:  Stéphane Laurent; Sandrine Katsahian; Céline Fassot; Anne-Isabelle Tropeano; Isabelle Gautier; Brigitte Laloux; Pierre Boutouyrie
Journal:  Stroke       Date:  2003-04-03       Impact factor: 7.914

5.  Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study.

Authors:  Pierre Boutouyrie; Anne Isabelle Tropeano; Roland Asmar; Isabelle Gautier; Athanase Benetos; Patrick Lacolley; Stéphane Laurent
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

6.  Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.

Authors:  Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Michael H Olsen
Journal:  J Hypertens       Date:  2012-10       Impact factor: 4.844

7.  Uric acid and endothelial dysfunction in essential hypertension.

Authors:  Carmine Zoccali; Raffaele Maio; Francesca Mallamaci; Giorgio Sesti; Francesco Perticone
Journal:  J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 10.121

8.  Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques.

Authors:  Noor A Jatoi; Azra Mahmud; Kathleen Bennett; John Feely
Journal:  J Hypertens       Date:  2009-11       Impact factor: 4.844

9.  Serum uric acid: marker for atherosclerosis as it is positively associated with "atherogenic index of plasma".

Authors:  Simant Baliarsingh; Neha Sharma; Ranadip Mukherjee
Journal:  Arch Physiol Biochem       Date:  2012-10-19       Impact factor: 4.076

Review 10.  Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.

Authors:  Alastair J S Webb; Urs Fischer; Ziyah Mehta; Peter M Rothwell
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

View more
  4 in total

1.  CARDIOVASCULAR RISK ASSESSMENT IN THE ADULT (AGED 40-79 YEARS) ROMANIAN POPULATION.

Authors:  M M Rosu; S G Popa; E Mota; A Popa; M Manolache; C Guja; C Bala; C Mota; M Mota
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Apr-Jun       Impact factor: 0.877

2.  Atherosclerosis risk assessment in patients with chronic obstructive pulmonary disease: a case-control study.

Authors:  Himanshu Sharma; Prem Kapur; Rajinder K Jalali; Kiran Dubey
Journal:  Ther Clin Risk Manag       Date:  2019-08-29       Impact factor: 2.423

3.  Investigation of the accuracy of a noninvasive continuous blood pressure device in different age groups and its ability in detecting hypertension and hypotension: an observational study.

Authors:  Ziwei Wang; Guizhen Chen; Kaizhi Lu; Yuan Zhu; Yan Chen
Journal:  BMC Anesthesiol       Date:  2019-12-05       Impact factor: 2.217

4.  Noninvasive Blood Pressure Measurement Using the NICCI Monitor in Adolescents During Intraoperative Anesthetic Care.

Authors:  Kwaku Owusu-Bediako; Ismail Bekiroglu; Julie Rice-Weimer; Marcelino Murillo-Deluquez; Joseph D Tobias
Journal:  Cardiol Res       Date:  2022-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.